According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...

Industry sources told Capital Brief they expect KKR to begin laying the groundwork for an exit this year - but not everyone ...

Donald Trump's rapid-fire announcement of one extraordinary policy after another in the first days of his second presidency ...

KKR & Co's fourth-quarter assets under management fell short of expectations on Tuesday, dampening the optimism ...